170 related articles for article (PubMed ID: 35319914)
1. Effect of Prostate MRI Interpretation Experience on PPV Using PI-RADS Version 2: A 6-Year Assessment Among Eight Fellowship-Trained Radiologists.
Salka BR; Shankar PR; Troost JP; Khalatbari S; Davenport MS
AJR Am J Roentgenol; 2022 Sep; 219(3):453-460. PubMed ID: 35319914
[No Abstract] [Full Text] [Related]
2. Prostate Imaging and Data Reporting System Version 2 as a Radiology Performance Metric: An Analysis of 18 Abdominal Radiologists.
Davenport MS; Downs E; George AK; Curci NE; Salka BR; Sullivan TQ; Shankar PR
J Am Coll Radiol; 2021 Aug; 18(8):1069-1076. PubMed ID: 33848507
[TBL] [Abstract][Full Text] [Related]
3. Utility of dual read in the setting of prostate MRI interpretation.
Harfouch N; Peti S; Sharma R; Chacko J; Emmanuel G; Hayim M; Yarmish G
Abdom Radiol (NY); 2023 Apr; 48(4):1395-1400. PubMed ID: 36881131
[TBL] [Abstract][Full Text] [Related]
4. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
[No Abstract] [Full Text] [Related]
5. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
6. Interobserver Agreement and Positivity of PI-RADS Version 2 Among Radiologists with Different Levels of Experience.
Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DR; de Souza Leão LR; Luz DC; Martins T; Baroni RH
Acad Radiol; 2019 Aug; 26(8):1017-1022. PubMed ID: 30268722
[TBL] [Abstract][Full Text] [Related]
7. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
Sheridan AD; Nath SK; Syed JS; Aneja S; Sprenkle PC; Weinreb JC; Spektor M
AJR Am J Roentgenol; 2018 Feb; 210(2):347-357. PubMed ID: 29112469
[TBL] [Abstract][Full Text] [Related]
8. Radiologists' Contribution to Variation in Detecting Clinically Significant Prostate Cancer in Men With Prostate MRI.
Naik S; Burk KS; Budiawan E; Lacson R; Lee LK; Fennessy FM; Tempany C; Cole AP; Trinh QD; Kibel AS; Khorasani R
J Am Coll Radiol; 2022 Dec; 19(12):1312-1321. PubMed ID: 36244674
[TBL] [Abstract][Full Text] [Related]
9. Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation.
Shankar PR; Kaza RK; Al-Hawary MM; Masch WR; Curci NE; Mendiratta-Lala M; Sakala MD; Johnson TD; Davenport MS
Radiology; 2018 Jul; 288(1):158-163. PubMed ID: 29664338
[TBL] [Abstract][Full Text] [Related]
10. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
Westphalen AC; McCulloch CE; Anaokar JM; Arora S; Barashi NS; Barentsz JO; Bathala TK; Bittencourt LK; Booker MT; Braxton VG; Carroll PR; Casalino DD; Chang SD; Coakley FV; Dhatt R; Eberhardt SC; Foster BR; Froemming AT; Fütterer JJ; Ganeshan DM; Gertner MR; Mankowski Gettle L; Ghai S; Gupta RT; Hahn ME; Houshyar R; Kim C; Kim CK; Lall C; Margolis DJA; McRae SE; Oto A; Parsons RB; Patel NU; Pinto PA; Polascik TJ; Spilseth B; Starcevich JB; Tammisetti VS; Taneja SS; Turkbey B; Verma S; Ward JF; Warlick CA; Weinberger AR; Yu J; Zagoria RJ; Rosenkrantz AB
Radiology; 2020 Jul; 296(1):76-84. PubMed ID: 32315265
[TBL] [Abstract][Full Text] [Related]
11. Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
Curci NE; Lane BR; Shankar PR; Noyes SL; Moriarity AK; Kubat A; Brede C; Montgomery JS; Auffenberg GB; Miller DC; Montie JE; George AK; Davenport MS
Urology; 2018 Jun; 116():137-143. PubMed ID: 29653121
[TBL] [Abstract][Full Text] [Related]
12. Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.
Rosenkrantz AB; Babb JS; Taneja SS; Ream JM
Radiology; 2017 Apr; 283(1):119-129. PubMed ID: 27783538
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of PI-RADS 4 lesions within the prostatic peripheral zone: a retrospective diagnostic accuracy study evaluating 170 lesions.
Shankar PR; Curci NE; Davenport MS
Abdom Radiol (NY); 2018 Aug; 43(8):2176-2182. PubMed ID: 29198006
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
[TBL] [Abstract][Full Text] [Related]
15. Comparison of PI-RADS version 2.1 and PI-RADS version 2 regarding interreader variability and diagnostic accuracy for transition zone prostate cancer.
Xu L; Zhang G; Zhang D; Zhang X; Bai X; Yan W; Zhou Y; Zhou Z; Xiao Y; Jin Z; Sun H
Abdom Radiol (NY); 2020 Dec; 45(12):4133-4141. PubMed ID: 32918577
[TBL] [Abstract][Full Text] [Related]
16. Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.
Arcot R; Sekar S; Kotamarti S; Krischak M; Michael ZD; Foo WC; Huang J; Polascik TJ; Gupta RT
Abdom Radiol (NY); 2022 Aug; 47(8):2917-2927. PubMed ID: 35674785
[TBL] [Abstract][Full Text] [Related]
17. Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer.
Patel NU; Lind KE; Garg K; Crawford D; Werahera PN; Pokharel SS
Abdom Radiol (NY); 2019 Feb; 44(2):705-712. PubMed ID: 30171296
[TBL] [Abstract][Full Text] [Related]
18. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
[TBL] [Abstract][Full Text] [Related]
19. Radiologists' preferences regarding content of prostate MRI reports: a survey of the Society of Abdominal Radiology.
Spilseth B; Margolis DJ; Ghai S; Patel NU; Rosenkrantz AB
Abdom Radiol (NY); 2018 Jul; 43(7):1807-1812. PubMed ID: 29128994
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
